Reprise Biomedical
Mr. Root co-founded Vascular Solutions, Inc. in 1997 and served as its Chief Executive Officer from inception of the company through its sale to Teleflex Incorporated in February 2017 for $1 billion. Under Mr. Root’s leadership, Vascular Solutions developed and commercialized over 100 new medical devices that are used to diagnose and treat a variety of vascular diseases ranging from acute myocardial infarction to varicose veins. From 1990 to 1995, Mr. Root was employed by ATS Medical, Inc., a mechanical heart valve medical device company, as Vice President and General Counsel. Previous thereto, Mr. Root practiced corporate law at the law firm of Dorsey & Whitney LLP for over five years, specializing in representing emerging growth companies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Reprise Biomedical
Reprise Biomedical is a Minnesota-based startup focused on commercializing biological medical devices manufactured using a proprietary perfusion decellularization technology that supports cellular integration. Reprise was created in connection with a spin-off from Miromatrix Medical Inc. in June 2019.